Barnes Jewish West County Hospital - Medicare Primary Care in Creve Coeur, MO

Barnes Jewish West County Hospital is a medicare enrolled primary clinic (General Practice) in Creve Coeur, Missouri. The current practice location for Barnes Jewish West County Hospital is 12634 Olive Blvd, Creve Coeur, Missouri. For appointments, you can reach them via phone at (314) 996-8000. The mailing address for Barnes Jewish West County Hospital is 12634 Olive Blvd, Creve Coeur, Missouri and phone number is (314) 996-8000.

Barnes Jewish West County Hospital is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1447268495. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (314) 996-8000.

Contact Information

Barnes Jewish West County Hospital
12634 Olive Blvd
Creve Coeur
MO 63141-6337
(314) 996-8000
(314) 996-3610

Primary Care Clinic Profile

Full NameBarnes Jewish West County Hospital
SpecialityGeneral Practice
Location12634 Olive Blvd, Creve Coeur, Missouri
Authorized Official Name and PositionGregory Patterson (PRESIDENT)
Authorized Official Contact3143625909
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Barnes Jewish West County Hospital
12634 Olive Blvd
Creve Coeur
MO 63141-6337

Ph: (314) 996-8000
Barnes Jewish West County Hospital
12634 Olive Blvd
Creve Coeur
MO 63141-6337

Ph: (314) 996-8000

NPI Details:

NPI Number1447268495
Provider Enumeration Date08/04/2006
Last Update Date01/20/2023

Medicare PECOS Information:

Medicare PECOS PAC ID2567468259
Medicare Enrollment IDO20070502000085

News Archive

Researchers successfully convert skin cells into fully functional placenta-generating cells

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are capable of long-term growth, self-renewal, and can give rise to every cell, tissue and organ in the fetus's body.

Natural variation shows promise for increasing provitamin A in cassava roots

The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.

Neuropeptide receptors could provide treatment target for chemoresistant SCLC

The discovery of a novel broad spectrum neuropeptide antagonist, peptide–1, which is related to the substance P analogue SP-G, could help develop treatments targeted at chemoresistant small-cell lung cancer, indicate study results.

Final results from Alnylam's ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

Quicker recovery time with new laparoscopic hysterectomy

More than 600,000 hysterectomies are performed every year in the United States at a cost of $5 billion, which doesn't take into account the 144 million work hours lost to the average six-week recovery time. Billie Williams of Grapevine had been considering having one for years, but major surgery and a long convalescence didn't fit with her plans.

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Barnes Jewish West County Hospital such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1447268495NPI-NPPES
0518719OtherAETNA HMO/POS
6350680OtherAETNA PPO
260162OtherMERCY
16OtherBLUE CROSS
542778402MedicaidMO
7723X7723OtherHEALTHCARE USA
012778403MedicaidMO
117292OtherHEALTHLINK

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208D00000XGeneral Practice (* (Not Available))Primary
282N00000XGeneral Acute Care Hospital (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Barnes Jewish West County Hospital acts as a billing entity for following providers:
Provider NameNancy C Bradley
Provider TypePractitioner - Registered Dietitian Or Nutrition Professional
Provider IdentifiersNPI Number: 1336395839
PECOS PAC ID: 0042486888
Enrollment ID: I20111229000214

News Archive

Researchers successfully convert skin cells into fully functional placenta-generating cells

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are capable of long-term growth, self-renewal, and can give rise to every cell, tissue and organ in the fetus's body.

Natural variation shows promise for increasing provitamin A in cassava roots

The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.

Neuropeptide receptors could provide treatment target for chemoresistant SCLC

The discovery of a novel broad spectrum neuropeptide antagonist, peptide–1, which is related to the substance P analogue SP-G, could help develop treatments targeted at chemoresistant small-cell lung cancer, indicate study results.

Final results from Alnylam's ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

Quicker recovery time with new laparoscopic hysterectomy

More than 600,000 hysterectomies are performed every year in the United States at a cost of $5 billion, which doesn't take into account the 144 million work hours lost to the average six-week recovery time. Billie Williams of Grapevine had been considering having one for years, but major surgery and a long convalescence didn't fit with her plans.

Read more Medical News

› Verified 1 days ago

Provider NameGail C Crofton
Provider TypePractitioner - Registered Dietitian Or Nutrition Professional
Provider IdentifiersNPI Number: 1265689418
PECOS PAC ID: 6305012147
Enrollment ID: I20111229000235

News Archive

Researchers successfully convert skin cells into fully functional placenta-generating cells

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are capable of long-term growth, self-renewal, and can give rise to every cell, tissue and organ in the fetus's body.

Natural variation shows promise for increasing provitamin A in cassava roots

The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.

Neuropeptide receptors could provide treatment target for chemoresistant SCLC

The discovery of a novel broad spectrum neuropeptide antagonist, peptide–1, which is related to the substance P analogue SP-G, could help develop treatments targeted at chemoresistant small-cell lung cancer, indicate study results.

Final results from Alnylam's ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

Quicker recovery time with new laparoscopic hysterectomy

More than 600,000 hysterectomies are performed every year in the United States at a cost of $5 billion, which doesn't take into account the 144 million work hours lost to the average six-week recovery time. Billie Williams of Grapevine had been considering having one for years, but major surgery and a long convalescence didn't fit with her plans.

Read more Medical News

› Verified 1 days ago

Provider NameElizabeth Plummer
Provider TypePractitioner - Registered Dietitian Or Nutrition Professional
Provider IdentifiersNPI Number: 1447913967
PECOS PAC ID: 0042608895
Enrollment ID: I20211202001648

News Archive

Researchers successfully convert skin cells into fully functional placenta-generating cells

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are capable of long-term growth, self-renewal, and can give rise to every cell, tissue and organ in the fetus's body.

Natural variation shows promise for increasing provitamin A in cassava roots

The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.

Neuropeptide receptors could provide treatment target for chemoresistant SCLC

The discovery of a novel broad spectrum neuropeptide antagonist, peptide–1, which is related to the substance P analogue SP-G, could help develop treatments targeted at chemoresistant small-cell lung cancer, indicate study results.

Final results from Alnylam's ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

Quicker recovery time with new laparoscopic hysterectomy

More than 600,000 hysterectomies are performed every year in the United States at a cost of $5 billion, which doesn't take into account the 144 million work hours lost to the average six-week recovery time. Billie Williams of Grapevine had been considering having one for years, but major surgery and a long convalescence didn't fit with her plans.

Read more Medical News

› Verified 1 days ago

Provider NameBrittany Metzger
Provider TypePractitioner - Registered Dietitian Or Nutrition Professional
Provider IdentifiersNPI Number: 1740851641
PECOS PAC ID: 7315329349
Enrollment ID: I20220808000438

News Archive

Researchers successfully convert skin cells into fully functional placenta-generating cells

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are capable of long-term growth, self-renewal, and can give rise to every cell, tissue and organ in the fetus's body.

Natural variation shows promise for increasing provitamin A in cassava roots

The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.

Neuropeptide receptors could provide treatment target for chemoresistant SCLC

The discovery of a novel broad spectrum neuropeptide antagonist, peptide–1, which is related to the substance P analogue SP-G, could help develop treatments targeted at chemoresistant small-cell lung cancer, indicate study results.

Final results from Alnylam's ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

Quicker recovery time with new laparoscopic hysterectomy

More than 600,000 hysterectomies are performed every year in the United States at a cost of $5 billion, which doesn't take into account the 144 million work hours lost to the average six-week recovery time. Billie Williams of Grapevine had been considering having one for years, but major surgery and a long convalescence didn't fit with her plans.

Read more Medical News

› Verified 1 days ago

News Archive

Researchers successfully convert skin cells into fully functional placenta-generating cells

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are capable of long-term growth, self-renewal, and can give rise to every cell, tissue and organ in the fetus's body.

Natural variation shows promise for increasing provitamin A in cassava roots

The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.

Neuropeptide receptors could provide treatment target for chemoresistant SCLC

The discovery of a novel broad spectrum neuropeptide antagonist, peptide–1, which is related to the substance P analogue SP-G, could help develop treatments targeted at chemoresistant small-cell lung cancer, indicate study results.

Final results from Alnylam's ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

Quicker recovery time with new laparoscopic hysterectomy

More than 600,000 hysterectomies are performed every year in the United States at a cost of $5 billion, which doesn't take into account the 144 million work hours lost to the average six-week recovery time. Billie Williams of Grapevine had been considering having one for years, but major surgery and a long convalescence didn't fit with her plans.

Read more News

› Verified 1 days ago


General Practice in Creve Coeur, MO

Mid-town Medical Practice, Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 9 Sackston Woods Ln, Creve Coeur, MO 63141
Phone: 314-651-6132    
Renewed Health 180 Lp
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 456 N New Ballas Rd Ste 101a, Creve Coeur, MO 63141
Phone: 314-866-9940    
Top Medical Center Lp
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 456 N New Ballas Rd Ste 101, Creve Coeur, MO 63141
Phone: 314-384-3600    
4ever-young
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 11716 Studt Ave, Creve Coeur, MO 63141
Phone: 314-330-8117    
Allies 4 Health Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 522 N New Ballas Rd Ste 245, Creve Coeur, MO 63141
Phone: 314-472-8333    
Midwest Consulting And Ime
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 763 S New Ballas Rd, Suite 230, Creve Coeur, MO 63141
Phone: 314-681-2800    Fax: 314-432-5088
Missouri Pain Specialists, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 12607 Olive Blvd, Creve Coeur, MO 63141
Phone: 314-327-8070    Fax: 314-228-1891

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.